Carles Ubeda

Summary

Country: Spain

Publications

  1. pmc Intestinal microbiota containing Barnesiella species cures vancomycin-resistant Enterococcus faecium colonization
    Carles Ubeda
    Infectious Diseases Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York, USA
    Infect Immun 81:965-73. 2013
  2. pmc Familial transmission rather than defective innate immunity shapes the distinct intestinal microbiota of TLR-deficient mice
    Carles Ubeda
    Infectious Diseases Service, Department of Medicine, Sloan Kettering Institute, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA
    J Exp Med 209:1445-56. 2012
  3. pmc Antibiotics, microbiota, and immune defense
    Carles Ubeda
    Department of Genomics and Health, Center for Advanced Research in Public Health, Valencia 46020, Spain
    Trends Immunol 33:459-66. 2012
  4. pmc Intestinal domination and the risk of bacteremia in patients undergoing allogeneic hematopoietic stem cell transplantation
    Ying Taur
    Infectious Disease Service, Department of Medicine, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA
    Clin Infect Dis 55:905-14. 2012
  5. pmc Profound alterations of intestinal microbiota following a single dose of clindamycin results in sustained susceptibility to Clostridium difficile-induced colitis
    Charlie G Buffie
    Infectious Diseases Service, Department of Medicine, Lucille Castori Center for Microbes, Inflammation and Cancer, Sloan Kettering Institute, Memorial Sloan Kettering Cancer Center, New York, New York, USA
    Infect Immun 80:62-73. 2012
  6. pmc Regulation of intestinal inflammation by microbiota following allogeneic bone marrow transplantation
    Robert R Jenq
    Adult Bone Marrow Transplantation Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA
    J Exp Med 209:903-11. 2012
  7. pmc Bacterial flagellin stimulates Toll-like receptor 5-dependent defense against vancomycin-resistant Enterococcus infection
    Melissa A Kinnebrew
    Infectious Diseases Service, Department of Medicine, Immunology Program, Memorial Sloan Kettering Cancer Center, New York, New York, USA
    J Infect Dis 201:534-43. 2010
  8. pmc Vancomycin-resistant Enterococcus domination of intestinal microbiota is enabled by antibiotic treatment in mice and precedes bloodstream invasion in humans
    Carles Ubeda
    Infectious Diseases Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York, USA
    J Clin Invest 120:4332-41. 2010
  9. pmc Periodontal disease and the oral microbiota in new-onset rheumatoid arthritis
    Jose U Scher
    Division of Rheumatology, New York University and New York University Hospital for Joint Diseases, New York, New York 10003, USA
    Arthritis Rheum 64:3083-94. 2012
  10. pmc Vancomycin-resistant enterococci exploit antibiotic-induced innate immune deficits
    Katharina Brandl
    Infectious Diseases Service, Department of Medicine, Immunology Program, Sloan Kettering Institute, New York, New York, USA
    Nature 455:804-7. 2008

Collaborators

Detail Information

Publications10

  1. pmc Intestinal microbiota containing Barnesiella species cures vancomycin-resistant Enterococcus faecium colonization
    Carles Ubeda
    Infectious Diseases Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York, USA
    Infect Immun 81:965-73. 2013
    ..Our studies indicate that obligate anaerobic bacteria belonging to the Barnesiella genus enable clearance of intestinal VRE colonization and may provide novel approaches to prevent the spread of highly antibiotic-resistant bacteria...
  2. pmc Familial transmission rather than defective innate immunity shapes the distinct intestinal microbiota of TLR-deficient mice
    Carles Ubeda
    Infectious Diseases Service, Department of Medicine, Sloan Kettering Institute, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA
    J Exp Med 209:1445-56. 2012
    ....
  3. pmc Antibiotics, microbiota, and immune defense
    Carles Ubeda
    Department of Genomics and Health, Center for Advanced Research in Public Health, Valencia 46020, Spain
    Trends Immunol 33:459-66. 2012
    ..We further discuss how antibiotic-induced disruption of the microbiota and immune homeostasis can lead to disease and we review strategies to restore immune defenses during antibiotic administration...
  4. pmc Intestinal domination and the risk of bacteremia in patients undergoing allogeneic hematopoietic stem cell transplantation
    Ying Taur
    Infectious Disease Service, Department of Medicine, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA
    Clin Infect Dis 55:905-14. 2012
    ..We examined the microbiota of patients undergoing allo-HSCT, and correlated microbial shifts with the risk of bacteremia...
  5. pmc Profound alterations of intestinal microbiota following a single dose of clindamycin results in sustained susceptibility to Clostridium difficile-induced colitis
    Charlie G Buffie
    Infectious Diseases Service, Department of Medicine, Lucille Castori Center for Microbes, Inflammation and Cancer, Sloan Kettering Institute, Memorial Sloan Kettering Cancer Center, New York, New York, USA
    Infect Immun 80:62-73. 2012
    ..difficile infection at least 10 days following clindamycin, suggesting that resolution of diarrhea and weight gain may result from the activation of mucosal immune defenses...
  6. pmc Regulation of intestinal inflammation by microbiota following allogeneic bone marrow transplantation
    Robert R Jenq
    Adult Bone Marrow Transplantation Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA
    J Exp Med 209:903-11. 2012
    ..Together, these data demonstrate regulation of flora by intestinal inflammation and suggest that flora manipulation may reduce intestinal inflammation and improve outcomes for allogeneic BMT recipients...
  7. pmc Bacterial flagellin stimulates Toll-like receptor 5-dependent defense against vancomycin-resistant Enterococcus infection
    Melissa A Kinnebrew
    Infectious Diseases Service, Department of Medicine, Immunology Program, Memorial Sloan Kettering Cancer Center, New York, New York, USA
    J Infect Dis 201:534-43. 2010
    ..By enhancing mucosal resistance to multidrug-resistant organisms, flagellin administration may provide a clinically useful approach to prevent infections in patients treated with broad-spectrum antibiotics...
  8. pmc Vancomycin-resistant Enterococcus domination of intestinal microbiota is enabled by antibiotic treatment in mice and precedes bloodstream invasion in humans
    Carles Ubeda
    Infectious Diseases Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York, USA
    J Clin Invest 120:4332-41. 2010
    ..Thus, high-throughput DNA sequencing of the intestinal microbiota could identify patients at high risk of developing bacterial sepsis...
  9. pmc Periodontal disease and the oral microbiota in new-onset rheumatoid arthritis
    Jose U Scher
    Division of Rheumatology, New York University and New York University Hospital for Joint Diseases, New York, New York 10003, USA
    Arthritis Rheum 64:3083-94. 2012
    ..To profile the abundance and diversity of subgingival oral microbiota in patients with never-treated, new-onset rheumatoid arthritis (RA)...
  10. pmc Vancomycin-resistant enterococci exploit antibiotic-induced innate immune deficits
    Katharina Brandl
    Infectious Diseases Service, Department of Medicine, Immunology Program, Sloan Kettering Institute, New York, New York, USA
    Nature 455:804-7. 2008
    ....